Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effects of Hydroxychloroquine on Pregnancy Outcomes in Infertile Women: A Systematic Review and Meta-Analysis Publisher Pubmed



Mirzaei M1 ; Amirajam S2 ; Moghimi ES3 ; Behzadi S4 ; Rohani A5 ; Zerangian N6 ; Samani NK7, 8 ; Soudagar S9 ; Ghazanfarpour M10
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Obstetrics and Gynecology, Faculty of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran
  2. 2. Avicenna Infertility Clinic, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
  3. 3. Department of Community Health Nursing, Vali Asr Nursery, Shiraz, Iran
  4. 4. School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Department of Educational Psychology, Islamic Azad University Mobarakeh Branch, Esfahan, Iran
  6. 6. School of Public Health, Iran University of Medical Sciences, Tehran, Iran
  7. 7. School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. Social Security Organization, Isfahan University of Medical Sciences, Isfahan, Iran
  9. 9. Department of Nursing, Faculty of Nursing and Midwifery, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  10. 10. Kerman University of Medical Sciences, Kerman, Iran

Source: Journal of Medicine and Life Published:2023


Abstract

A promising strategy for controlling repeated implantation failure (RIF) may be the use of hydroxychloroquine (HCQ). To the best of our knowledge, no systematic review has been conducted on the effects of hydroxychloro-quine on pregnancy outcomes. A systematic research of the following electronic databases was conducted: Cochrane, EMBASE-Ovid, PubMed, Web of Science, and Scopus from inception to December 2021, using the following key-words [hydroxychloroquine] AND [infertility]. Fertilization and rate of live birth were significantly higher in the HCQ+ prednisone (PDN) group than in the PDN alone group. However, the abortion rate was not different between the two groups. The meta-analysis of two studies revealed no statistical significance between the PDN group and HCQ+PDN group regarding clinical pregnancy rate (OR=.14 [95%CI: 0.4–4.370]; heterogeneity; P=0.13; I2=54%; random effect model) and implantation rate (OR=1.99 [95%CI: 0.94–4.2]; heterogeneity; P=0.37; I2=0%; fixed-effect model). While HCQ may help improve fertilization and live birth rates, adding it to prednisone did not improve overall pregnancy outcomes. This systematic review should be used with caution due to the small size, study design, and difference in the studies' population. © 2023 JOURNAL of MEDICINE and LIFE.